Effects of aluminum-salt, CpG and emulsion adjuvants on the stability and immunogenicity of a virus-like particle displaying the SARS-CoV-2 receptor-binding domain (RBD)HUMAN VACCINES & IMMUNOTHERAPEUTICSIF3.52023-11-061OAAI
Formulation Studies to Develop Low-Cost, Orally-Delivered Secretory IgA Monoclonal Antibodies for Passive Immunization Against Enterotoxigenic Escherichia coliJOURNAL OF PHARMACEUTICAL SCIENCESIF3.82023-07-011OAAI
Nanoalum Formulations Containing Aluminum Hydroxide and CpG 1018™ Adjuvants: The Effect on Stability and Immunogenicity of a Recombinant SARS-CoV-2 RBD AntigenVACCINESIF3.42023-05-260OAAI
Minimal purification method enables developability assessment of recombinant proteinsBIOTECHNOLOGY AND BIOENGINEERINGIF3.62023-04-030OAAI
Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvantsHUMAN VACCINES & IMMUNOTHERAPEUTICSIF3.52022-06-0616OAAI
SARS-CoV-2 receptor binding domain displayed on HBsAg virus-like particles elicits protective immunity in macaquesHBsAg病毒样颗粒上显示的SARS-CoV-2受体结合域在猕猴中引起保护性免疫SCIENCE ADVANCESIF12.52022-03-1822OAAI
Prophylactic Activity of Orally Administered FliD-Reactive Monoclonal SIgA Against Campylobacter InfectionFRONTIERS IN IMMUNOLOGYIF5.92020-06-0910OAAI